Top Markets
Coin of the day
Ortin Laboratories Limited Ortin Laboratories Limited

Ortin Laboratories Limited

ORTINLAB
株式のランク #37115
Ortin Laboratories Limited, a pharmaceutical company established in Hyderabad,... Ortin Laboratories Limited, a pharmaceutical company established in Hyderabad, India, in 1986, is engaged in the manufacturing and commercialization of a diverse range of medicines, drugs, and chemical intermediates. The company provides a wide array of pharmaceutical formulations, presented as tablets, capsules, syrups, and dry powders. These products target various therapeutic domains such as metabolic diseases (e.g., anti-diabetics), allergic reactions, infections (including broad-spectrum antibiotics and antifungals like quinolones, penicillins, cephalosporins, macrolides, and antifungals), pain management and fever reduction (analgesics and antipyretics), cardiovascular ailments (anti-anginal and cardiovascular products), digestive system disorders (antacids and anti-ulcerants), neurological and psychiatric conditions (sedatives, tranquilizers, psychiatry products), and nutritional supplementation (like vitamins, calcium, iron, and protein supplements). Specialized offerings also include anti-retroviral, anti-arthritic, anti-helminthic, anti-spasmodic, gynaec, appetite stimulators, and chemotherapeutic preparations. In addition to finished pharmaceuticals, Ortin produces active pharmaceutical ingredient (API) intermediates for applications such as anti-retrovirals, anti-diabetics, pain and fever medications, antibiotics, antifungals, antacids, anti-malarials, and anti-ulcerants. Its manufacturing capabilities also extend to fine chemicals and Grignard/alkali metal compounds. The company offers specialized services covering process development and characterization, analytical research, assay development, and product characterization. It also contributes to diagnostics through the development of rapid flow kits, assays, and reagents. Ortin Laboratories undertakes long-term contracts for the production of intermediates and the creation of novel APIs. Moreover, it actively functions as a merchant exporter of its finished pharmaceutical products.
株価
$0.2488447
最終同期: 2024-10-01
時価総額
$2.01M
変化(1日)
-1.88%
変化(1年)
0.00%
IN
取引 Ortin Laboratories Limited (ORTINLAB)

カテゴリー

Ortin Laboratories Limited(ORTINLAB)の営業利益率
August 2026 時点の営業利益率 TTM: -989.65%
Ortin Laboratories Limited の最新の財務報告と株価によると、現在の営業利益率(TTM)は -989.65% です。2023 年末時点では 4.50% でした。
Ortin Laboratories Limited の営業利益率の履歴(2008 から 2026)
各年末の営業利益率
営業利益率 変化
2026 (TTM) -989.65% 208.87%
2024 -320.41% -7,220.22%
2023 4.50% 15.98%
2022 3.88% -66.98%
2021 11.75% 505.67%
2020 1.94% -35.76%
2019 3.02% -36.02%
2018 4.72% 95.85%
2017 2.41% -31.34%
2016 3.51% 3.24%
2015 3.40% 14.48%
2014 2.97% -5.71%
2013 3.15% 3.62%
2012 3.04% -10.32%
2011 3.39% -18.31%
2010 4.15% 24.62%
2009 3.33% -35.09%
2008 5.13% 0.00%
同業他社の営業利益率
企業の営業利益率とは?
営業利益率は、企業の収益性を評価するための重要な指標です。高い営業利益率は一般的に良いとされており、企業が製品やサービスをその生産コストよりもはるかに高く販売できていることを示します。営業利益率は、企業の利益を売上高で割ることで計算されます。